Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
TVTX Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/tvtx/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Travere Therapeutics, Inc. (TVTX) Insider Trading

19 open-market trades reported since Jun 16, 2026: 0 purchases worth $0 and 19 sales worth $80.9M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Eric M. DubeCEO0$04$38.5MOct 19, 2026
Peter HeermaEVP0$03$17.9MSep 17, 2026
William E. RoteChief Research Officer0$02$13.1MSep 17, 2026
Christopher R. ClineCFO0$02$3.19MSep 17, 2026
Jula InrigEVP0$01$2.79MSep 17, 2026
Elizabeth E. ReedGeneral Counsel0$01$2.34MSep 17, 2026
Sandra CalvinCAO0$01$335KSep 17, 2026
Jeffrey A. MecklerDirector0$01$1.35MSep 11, 2026
Gary A. LyonsDirector0$02$633KAug 19, 2026
Timothy CoughlinDirector0$01$501KJun 16, 2026
Roy D. BaynesDirector0$01$225KJun 16, 2026

All trades

TVTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 19Oct 15Eric M. DubeCEOCEO▼ SELL10b5-1243,73553.82$13.1M−36%Form 4 ↗
Sep 17Sep 16Eric M. DubeCEOCEO▼ SELL10b5-1195,84163.45$12.4M−31%Form 4 ↗
Sep 17Sep 16Peter HeermaEVPEVP▼ SELL10b5-1172,71763.43$11.0M−60%Form 4 ↗
Sep 17Sep 16William E. RoteChief Research OfficerChief Research Officer▼ SELL10b5-1112,85063.33$7.15M−44%Form 4 ↗
Sep 17Sep 17Eric M. DubeCEOCEO▼ SELL10b5-1108,49364.61$7.01M−20%Form 4 ↗
Sep 17Sep 15Peter HeermaEVPEVP▼ SELL10b5-1102,19062.26$6.36M−47%Form 4 ↗
Sep 17Sep 15William E. RoteChief Research OfficerChief Research Officer▼ SELL10b5-196,19862.25$5.99M−50%Form 4 ↗
Sep 17Sep 15Eric M. DubeCEOCEO▼ SELL10b5-195,66662.26$5.96M−18%Form 4 ↗
Sep 17Sep 15Christopher R. ClineCFOCFO▼ SELL10b5-150,50862.34$3.15M−37%Form 4 ↗
Sep 17Sep 15Jula InrigEVPEVP▼ SELL10b5-144,67462.34$2.79M−31%Form 4 ↗
Sep 17Sep 15Elizabeth E. ReedGeneral CounselGeneral Counsel▼ SELL10b5-137,50062.34$2.34M−26%Form 4 ↗
Sep 17Sep 17Peter HeermaEVPEVP▼ SELL10b5-18,28265.07$539K−6.6%Form 4 ↗
Sep 17Sep 15Sandra CalvinCAOCAO▼ SELL10b5-15,37562.33$335K−11%Form 4 ↗
Sep 11Sep 10Jeffrey A. MecklerDirectorDirector▼ SELL10b5-120,00067.31$1.35M−18%Form 4 ↗
Sep 3Sep 2Christopher R. ClineCFOCFO▼ SELL64266.37$43K−0.5%Form 4 ↗
Aug 19Aug 18Gary A. LyonsDirectorDirector▼ SELL10b5-15,00063.37$317K−7.5%Form 4 ↗
Aug 19Aug 17Gary A. LyonsDirectorDirector▼ SELL10b5-15,00063.20$316K−7.5%Form 4 ↗
Jun 16Jun 12Timothy CoughlinDirectorDirector▼ SELL10b5-110,00050.07$501K−15%Form 4 ↗
Jun 16Jun 12Roy D. BaynesDirectorDirector▼ SELL10b5-14,50050.00$225K−9.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings